New AusBiotech membership aims to help Australia’s early-stage life sciences founders thrive

Latest NewsAusBiotech

AusBiotech has launched a new membership category in its 40th year, AusBiotech Connect, designed specifically for companies in their first two years of operation.

The organisation said the new membership option aims to give Australia’s newest biotech, medtech and health tech founders support from day one.

It is intended as an accessible entry point into Australia’s largest life sciences business community, supporting founders to build relationships, gain industry knowledge and access opportunities that support long-term growth.

Members will receive access to AusBiotech member discounts, events and networking opportunities, the THRIVE newsletter and other member communications, learning and professional development activities, and discounted registration for Australia’s Biggest Week in Biotech, which includes the AusBiotech International and AusMedtech Conferences. Connect members will also have a voice in AusBiotech’s policy and advocacy agenda.

The membership targets early-stage, founder-led companies less than two years old as well as university, accelerator and innovation hub spinouts.

Annual membership is priced at $750 (inc GST).

AusBiotech said that companies operating for more than two years can still join through the organisation’s small, medium and large business membership categories.

Hayley van der Meer, AusBiotech Director of Membership and Engagement, said, "AusBiotech already proudly serves the needs of 3,500 members across some 450 organisations in every part of the biotech, medtech and health tech innovation ecosystem and we will continue to."

She added, "AusBiotech Connect has been designed to ensure we continue to meet our longstanding commitment to Australia's next generation of biotech, medtech and health tech innovators. Our goal is to ensure they can access the relationships, knowledge and opportunities they need from the very beginning of their journey and thrive as part of Australia’s largest life sciences business community."